Pérez-Álvarez R, García-Samaniego J, Solá, Pérez-López R, Bárcena R, Planas R,Cañete N, Manzano ML, Gutiérrez ML, Morano L, Rodrigo L.

Acute Hepatitis C in Spain : A Retrospective Study of 131 cases

Rev Esp Enf Dig. 2012;104:21-8

Pérez Álvarez R, Pérez López R, González Sotorrío N, Rodrigo Sáez L.

Porphyria Cutánea Tarda with Multiple Nodular Foci in the Liver

Gastroenterol y Hepatol. 2012;35:50-5

A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping

J Hepatol. 2012;56:1230-8

Álvarez-Martínez P, Granero-Castro P, Fernández-Vega I, Renilla-González A, Rodrigo-Sáez L, Varela-Calvo M

Carcinoma hepatocelular gigante

Rev Esp Enferm Dig. 2012; 104: 264-5

Álvarez-Martínez P, Pipa-Muñinz M, Ordieres-Diaz I, Palacio-Galan A, Granero-Castro P, Suárez-González A.

Poliposis múltiple linfomatosa intestinal como forma de presentación del linfoma de células del manto.

Rev Esp Enferm Dig. 2012; 104: 491-2

Barderas R., Babel I., Díaz-Uriarte R., Moreno V., Suárez A., Villar-Vázquez R., Capellá G., Casal I.

An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated  antigens obtained from protein and phage microarrays

J Proteomics 2012; 75: 4647-55

Altadill A, Eiró N, González LO, Junquera S, González-Quintana JM, Sánchez MR, Andicoechea A, Saro C, Rodrigo L, Vizoso FJ.

Comparative analysis of the expression of metalloproteases and their inhibitors in resected Crohn's disease and complicated Diverticular disease

Inflamm Bowel Dis. 2012;18:120-30.

Huidobro C, Urdinguio RG, Rodríguez RM, Mangas C, Calvanese V, Martínez-Camblor P, Ferrero C, Parra-Blanco A, Rodrigo L, Obaya AJ, Suárez-Fernández L, Astudillo A, Hernando H, Ballestar E, Fernández AF, Fraga MF

A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorrectal cancer

Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori erradication failures.

Rodrigo L, Pérez-Martinez I.

Osteogenesis Imperfecta with Celiac Disease and Type II Diabetes Mellitus Associated: Improvement with a Gluten-Free Diet.

Case Reports in Medicine.  2012;813461.

Castellví-Bel S, Ruiz-Ponte C, Fernández-Rozadilla C, Abulí A, Muñoz J, Bessa X, Brea-Fernández A, Ferro M, Giráldez MD, Xicola RM, Llor X, Jover R, Piqué JM, Andreu M, Castells A, Carracedo A; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association

Seeking genetic susceptibility variants for colorrectal cancer: the EPICOLON consortium experience.

Teruel M, Martin JE, Gómez-García M, Cardeña C, Rodrigo L, Nieto A, Alcain G, Cueto I, López-Nevot MA, Martin J.

Lack of association of ACP1 gene with inflammatory bowel disease: a case-control study.

Carcinogenesis. 2012;33:613-9.

Gómez R, Rodrigo L, Fidalgo A, Alonso C, Morís G.

Guillain-Barré and Miller Fisher syndromes in ulcerative colitis treated with infliximab.

Gisbert JP, Pérez-Aisa A, Bermejo F, Castro-Fernández M, Almela P, Barrio J, Cosme A, Modolell I, Bory F, Fernández-Bermejo M, Rodrigo L, Ortuño J, Sánchez-Pobre P, Khorrami S, Franco A, Tomas A, Guerra I, Lamas E, Ponce J, Calvet X; on behalf of the H. pylori Study Group of the Asociación Española de Gastroenterología (Spanish Gastroenterology Association).

Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection: Time Trends in a Spanish Multicenter Study of 1000 Patients.

Duodenal Expression of Toll-Like Receptors and Interleukins Are Increased in Both Children and Adult Celiac Patients.

Elguezábal N, Chamorro S, Molina E, Garrido JM, Izeta A, Rodrigo L, Juste RA.

Lactase persistente, NOD2 status and Mycobacterium avium subsp. Paratuberculosis infection associations to Inflammatory Bowel Disease.

Dellinger EP, Forsmark CE, Layer P, Lévy P, Maraví-Poma E, Petrov MS, Shimosegawa T, Siriwardena AK, Uomo G, Whitcomb DC, Windsor JA, Abu HM, Abu-Zidan F, Acosta J, Ainsworth A, Aizcorbe GM, Alagozlu H, Alʼaref S, Albeniz AE, Rodrigo L, et al.

Determinant-Based Classification of Acute Pancreatitis Severity: An International Multidisciplinary Consultation.

Fernandez-Rozadilla C, Cazier JB, Moreno V, Crous-Bou M, Guinó E, Durán G, Lamas MJ, López R, Candamio S, Gallardo E, Paré L, Baiget M, Páez D, López-Fernández LA, Cortejoso L, García MI, Bujanda L, González D, Gonzalo V, Rodrigo L, Reñé JM, Jover R, Brea-Fernández A, Andreu M, Bessa X, Llor X, Xicola R, Palles C, Tomlinson I, Castellví-Bel S, Castells A, Ruiz-Ponte C, Carracedo A.

Pharmacogenomics in colorrectal cancer : a genome-wide association study to predict toxicity alter 5-fluoracil or FOLFOX administration.

Pharmacogenomics J. 2012 Feb 7. doi:0.1038/tpj.2012.2.

Moreno A, Cervera C, Fortún J, Blanes M, Montejo E, Abradelo M, Len O, Rafecas A, Martín-Davila P, Torre-Cisneros J, Salcedo M, Cordero E, Lozano R, Pérez I, Rimola A, Miró JM; OLT-HIV FIPSE Cohort Investigators (Rodríguez M, González-Diéguez ML).

Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.

Liver Transpl 2012;18:70-81.

Miro JM, Montejo M, Castells L, Rafecas A, Moreno S, Agüero F, Abradelo M, Miralles P, Torre-Cisneros J, Pedreira JD, Cordero E, de la Rosa G, Moyano B, Moreno A, Perez I, Rimola A; Spanish OLT in HIV-Infected Patients Working Group investigators (Rodríguez M, González-Diéguez ML).

Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study.

Buti M; Morillas RM; Prieto M; Diago M; Pérez J; Solà R; Bonet L; Palau A; Testillano M; García-Samaniego J; Rodríguez M and the ORIENTE Study Group.

Efficacy and safety of entecavir in clinical practice in treatment-naïve Caucasian chronic hepatitis B patients.

Eur J Gastroenterol Hepatol 2012;24:535-42.

Buti M, García-Samaniego J, Prieto M, Rodríguez M, Sánchez-Tapias JM, Suárez E, Esteban R.

Documento de consenso de la AEEH sobre el tratamiento de la infección por el virus de la hepatitis B (2012).

Gastroenterol Hepatol 2012;35:512-28.

García-Bengoechea M, Hernández-López C, Crespo J y Gea F, en representación del grupo HEBRA (Rodríguez M)

Prácticas de cribado del virus de la hepatitis B previo a las terapias de riesgo de reactivación vírica en diferentes especialidades médicas. Proyecto HEBRA.

Med Clin (Barc). 2012;139:498–50.

S. Riestra Menéndez, R. de Francisco García, I. Pérez Martínez

Manejo extrahospitalario de la enfermedad inflamatoria intestinal: Papel de la Atención Primaria

Medicine 2012;11:291-300

Casellas F, Barreiro de Acosta M, Iglesias M, Robles V, Nos P, Aguas M, Riestra S, de Francisco R, Papo M, Borruel N.

Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease.

Eur J Gastroenterol Hepatol 2012; 24:762-9

Aguas M, Bastida G, Cerrillo E, Beltrán B, Iborra M, Sánchez-Montes C, Muñoz F, Barrio J, Riestra S, Nos P.

Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.

World J Gastroenterol. 2012;18:4391-8.

Riestra S.

Desintensificación del tratamiento con Adalimumab en pacientes con enfermedad de Crohn.

Evidencia vs experiencia. Publicaciones Permanyer 2012, pp 1-6. ISBN: 978-84-9926-326-7.

Riestra S, de Francisco R, Pérez-Martínez I.

Despistaje de tuberculosis en EII

Revista EIGA 2012;7:14-20.

Rodrigo L (Ed)

Acute Pancreatitis

Rodrigo L (Ed)

Acute Pancreatitis. Treatment and Complications.

Rodrigo L (Ed)

Enfermedad inflamatoria intestinal

Medicine (11ª serie). Unidad Temática 5. (Enfermedades del
Aparato Digestivo). Ed. Elsevier España. Madrid. 2012.
(págs.257-323) (www.medicineonline.es).